How Much Vitamin D Should I Take? The Big Trials Mostly Tested People Who Were Not Short of It.

Vitamin D works if you are short of it. That is the answer, and almost everything confusing about vitamin D comes from people leaving off the second half of that sentence.

The enormous trials you have seen reported as “vitamin D does nothing” were, to a large extent, testing supplements in people who already had enough. [1][2]

Which is a bit like testing whether water helps thirst by giving it to people who have just had a drink.

The strongest finding, and how they got it

A 2026 review did something more useful than pooling trials. It triangulated — comparing what three different kinds of study say, and looking for where they agree. [1]

Those three are: observational studies, which can be confounded by everything about a person’s life; randomised trials, which cannot be, but which are limited by who they recruit; and Mendelian randomisation, which is the clever one. It uses inherited genetic differences in vitamin D handling as a natural experiment — you did not choose your genes, so they are not confounded by your diet, your income or how much you go outside.

Where all three point the same way, you are probably looking at cause rather than coincidence. And on bone they do: “strong and consistent support for a causal role of vitamin D in skeletal health, particularly in the prevention and treatment of rickets and osteomalacia, and in fracture risk reduction among vitamin D-deficient and older populations.” [1]

Why the famous trials came back empty

Here is the sentence that explains a decade of contradictory headlines. Among the review’s listed problems with the field: “RCT designs that frequently enroll vitamin D-replete populations.” [1]

A second 2026 paper put a number on that. Researchers rebuilt two of the biggest vitamin D trials inside the UK Biobank — matching their entry criteria across 237,502 and 185,809 people — and then asked what those trials should have found. [2]

“When participants were weighted to match the trial baseline 25-hydroxyvitamin-D distributions, the expected effects became more similar to the largely null findings reported in the original trials.” [2]

In other words: reproduce the trials’ population, reproduce the trials’ nothing. Change the population to people who were actually deficient, and the picture changed.

And here our two sources disagree

We are going to leave this one open, because they genuinely do not agree and we have no business pretending otherwise.

That second paper found that among people who were insufficient or deficient, raising vitamin D was associated with significantly lower cardiovascular risk — a hazard ratio for cardiovascular death of 0.74 to 0.79. [2] Roughly a fifth to a quarter lower.

But it is a trial emulation, not a trial. It is observational work dressed in a trial’s clothing, and it can be confounded by things randomisation would have handled.

Meanwhile the triangulated review, which includes the genetic evidence, says flatly that cardiovascular associations are “not consistently supported by genetic or interventional evidence”. [1]

So: one paper says there is a real cardiovascular benefit hiding in the deficient, and another says the genetics do not back that up. Both were published this year. That is what an unsettled question looks like from the inside.

What is not in dispute is the list of nulls

The review is unambiguous about where the evidence does not go: “associations with cardiovascular disease, metabolic disorders, obesity, and most neuropsychiatric outcomes are not consistently supported by genetic or interventional evidence, suggesting limited or non-causal effects.” [1]

Obesity and metabolic disorders are on that list. If you are taking vitamin D because you read it helps with weight, that is the sentence to read twice.

The shape of the whole thing

One line captures why vitamin D behaves so strangely in the literature: the relationship is “non-linear… with increased risk concentrated at low 25-hydroxyvitamin D concentrations and limited benefit beyond sufficiency.” [1]

Steep at the bottom, flat after that. Being deficient is genuinely bad for you. Being twice as sufficient as you need to be is not twice as good, and probably not any better at all.

The verdict

Supported. Correcting a deficiency does real, causal good, most clearly for bone. Some other benefits appear at the low end and fade above it. And a long list of the things vitamin D is sold for — metabolic health, obesity, most mental health outcomes — is not supported.

The reviewers’ own summing up is better than ours: vitamin D “should be regarded neither as a universal panacea nor as a trivial supplement, but as a context-dependent hormone whose clinical value lies in outcome-specific correction of deficiency.” [1] And their recommendation follows: this “argues against indiscriminate population-wide supplementation.”

Which brings us to the question in the title, and to an answer you will not like. We are not going to tell you how much to take, because the entire finding on this page is that the right amount depends on a number you cannot feel and we cannot see.

Get the blood test. Then the question stops being “how much should I take” and becomes “am I short, and by how much” — which a doctor can actually answer, and a website cannot. Even what counts as “deficient” is still being argued over in the journals.

That is a duller answer than a number on a bottle. It is also the only one the evidence supports.

Related: magnesium benefits · does zinc help with colds · NAD+ supplements · methylene blue · every claim we’ve checked